IRIS
PURRELLO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.197
EU - Europa 9.306
AS - Asia 8.472
SA - Sud America 1.666
AF - Africa 1.176
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 37.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.585
SG - Singapore 4.331
RU - Federazione Russa 2.763
IT - Italia 2.417
CN - Cina 2.076
BR - Brasile 1.391
IE - Irlanda 1.304
UA - Ucraina 1.030
VN - Vietnam 767
CI - Costa d'Avorio 588
CA - Canada 474
FR - Francia 455
IN - India 317
DE - Germania 275
SE - Svezia 244
GB - Regno Unito 225
NG - Nigeria 205
KR - Corea 204
SN - Senegal 201
BD - Bangladesh 157
NL - Olanda 103
AR - Argentina 89
FI - Finlandia 84
PL - Polonia 83
HK - Hong Kong 76
TR - Turchia 76
JP - Giappone 72
MX - Messico 71
ZA - Sudafrica 71
IQ - Iraq 57
UZ - Uzbekistan 55
ES - Italia 50
CH - Svizzera 45
EC - Ecuador 45
CO - Colombia 44
AT - Austria 42
PK - Pakistan 36
IR - Iran 31
ID - Indonesia 29
VE - Venezuela 28
GR - Grecia 27
MA - Marocco 27
CL - Cile 26
LB - Libano 26
CZ - Repubblica Ceca 22
KE - Kenya 22
LT - Lituania 21
SA - Arabia Saudita 21
AU - Australia 20
BE - Belgio 19
BJ - Benin 14
AZ - Azerbaigian 13
EG - Egitto 13
PH - Filippine 13
PY - Paraguay 13
RO - Romania 13
BG - Bulgaria 12
JM - Giamaica 12
OM - Oman 12
AL - Albania 11
EU - Europa 11
JO - Giordania 11
PA - Panama 11
UY - Uruguay 11
NP - Nepal 10
PE - Perù 10
TH - Thailandia 10
TN - Tunisia 10
HR - Croazia 9
IL - Israele 9
KZ - Kazakistan 9
BO - Bolivia 8
CR - Costa Rica 8
KW - Kuwait 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
HU - Ungheria 7
KG - Kirghizistan 7
MY - Malesia 7
PS - Palestinian Territory 7
RS - Serbia 7
ET - Etiopia 6
SV - El Salvador 6
HN - Honduras 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GE - Georgia 4
IS - Islanda 4
MK - Macedonia 4
NI - Nicaragua 4
PT - Portogallo 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GT - Guatemala 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
Totale 37.809
Salva come PNG Salva come JPEG
Città #
Dallas 2.717
Singapore 2.553
Santa Clara 1.858
Chandler 1.403
Dublin 1.298
San Jose 1.241
Moscow 1.131
Jacksonville 1.068
Ashburn 818
Chicago 606
Abidjan 588
Boardman 546
Catania 372
Cambridge 355
Lawrence 355
Andover 347
Lauterbourg 343
Nanjing 341
Beijing 325
Los Angeles 313
Toronto 297
Hefei 292
Ho Chi Minh City 254
Civitanova Marche 252
Wilmington 222
Dakar 201
Seoul 201
Rome 193
Des Moines 190
Kochi 176
Milan 169
San Mateo 167
New York 164
Hanoi 159
Council Bluffs 154
São Paulo 125
Abuja 102
Buffalo 100
Nanchang 100
Shenyang 95
Houston 92
Palermo 91
Padova 88
Hebei 86
Lagos 78
The Dalles 78
Saint Petersburg 72
Ottawa 68
Dong Ket 67
Jiaxing 67
Hong Kong 65
Tokyo 65
Warsaw 64
Montreal 63
Orem 63
Columbus 62
Munich 60
Bremen 55
Brooklyn 48
Changsha 48
Johannesburg 47
Grafing 45
Rio de Janeiro 44
Atlanta 43
Stockholm 43
Tianjin 43
London 42
Phoenix 42
Denver 41
Amsterdam 38
Naples 37
San Francisco 37
Belo Horizonte 36
Chennai 36
Helsinki 35
Da Nang 34
Seattle 33
Lappeenranta 32
Boston 31
Istanbul 31
Poplar 31
Brasília 30
Frankfurt am Main 26
Tashkent 26
Manchester 25
Messina 25
Washington 24
Port Harcourt 23
Pune 23
Redondo Beach 23
San Giovanni la Punta 23
Augusta 22
Kunming 22
Mexico City 22
Carrara 21
Shanghai 21
Den Haag 20
Bari 19
Boydton 19
Dhaka 19
Totale 24.805
Salva come PNG Salva come JPEG
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 718
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 391
Il Rasario. Semeiotica medica 341
Criteri IDF e ATP-III per la diagnosi di sindrome metabolica: relazione con la prevalenza di steatosi epatica 276
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 263
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 224
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 219
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 204
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 193
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 185
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 183
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 175
A ten-year (1989-1998) perspective study of the incidence of Type 1 diabetes in the district of Catania (Sicily) in a 0-14 year age group 170
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 168
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 168
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 167
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 167
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 166
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 164
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 162
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 161
COPPER ADDITION PREVENTS THE INHIBITORY EFFECTS OF INTERLEUKIN-1-BETA ON RAT PANCREATIC-ISLETS 161
Antibiotic use and associated factors in a large sample of hospitalised older people 161
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 159
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 157
Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance 156
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 155
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 154
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 154
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 153
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 151
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma 151
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 150
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 150
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 149
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 148
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 148
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 148
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 147
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 147
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 146
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 145
Clinical and molecular biomarkers for diagnosis and staging of nafld 143
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 143
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 142
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 142
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 142
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 141
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 141
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 141
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 141
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 141
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 141
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 140
Heart failure and chronic kidney disease in a registry of internal medicine wards 140
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 139
Action of insulin at the nuclear envelope 138
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 138
Smoking and diabetes: Dangerous liaisons and confusing relationships 138
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 138
Alterazioni della funzione diastolica in pazienti con diabete tipo 2 neodiagnosticato 137
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 137
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 136
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 135
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 134
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 133
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 132
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 132
Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1β. Possible involvement of K+ and Ca2+ channels 131
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 131
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 130
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 128
A molecular Systems Medicine approach to Diabetes Mellitus pinpoints the molecular bases of the higher resistance to cytokine-induced apoptosis of mammalian pancreas α cells respect to β cells 128
Transient impairment of thyroid function in newborn from an area of endemic goiter 128
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 128
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 128
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 125
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 125
Glucose regulates both glucose transport and the glucose transporter gene expression in a hamster-derived pancreatic Beta-cell line (HIT) 124
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 124
Correlazione fra patologia tiroidea e presenza di anticorpi antitireoglobulina ed antimicrosomi tiroidei 124
ALTERAZIONI DELLA FUNZIONE DIASTOLICA IN PAZIENTI CON DIABETE DI TIPO 2 NEODIAGNOSTICATO 124
Anticorpi anti-GH in soggetti in trattamento con ormone della crescita: incidenza e possibile ruolo degli aggregati dell'ormone nella loro genesi 124
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 124
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 123
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 123
L’analogo dell’insulina Lispro riduce i picchi iperglicemici post-prandiali in soggetti con diabete tipo 2 123
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 123
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 123
Early effects of high-fat diet, extra-virgin olive oil and vitamin D in a sedentary rat model of non-alcoholic fatty liver disease. 123
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 123
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 120
.:FATTORI PROGNOSTICI DI GUARIGIONE DELLE ULCERE DEL PIEDE DIABETICO 120
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 119
Alterazioni molecolari del segnale insulinico e del metabolismo degli FFA in pazienti con NASH 118
Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets 118
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 118
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 118
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 118
Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms 117
Totale 15.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.656 289 362 17 66 427 58 377 102 218 11 103 626
2022/20234.336 386 200 65 417 406 742 23 802 1.023 30 149 93
2023/20242.049 110 308 103 116 86 440 39 169 23 63 341 251
2024/20258.501 736 1.188 466 499 1.607 852 294 272 520 760 758 549
2025/202616.117 924 693 3.023 1.085 2.428 3.085 1.949 345 789 879 475 442
2026/2027167 167 0 0 0 0 0 0 0 0 0 0 0
Totale 38.472